Musculoskeletal DisordersNCT06709677
Prevalence of Musculoskeletal Disorders
An observational study of Musculoskeletal Disorders and Among Egyptian Students in the Faculty of Applied Arts, run by Cairo University.
Trial summary
This observational cross-sectional study aims to determine the prevalence of musculoskeletal disorders (MSDs) among Egyptian students in the Faculty of Applied Arts. Using the Arabic version of the extended Nordic Musculoskeletal Questionnaire (NMQ-E), the study will assess the prevalence, distribution, and associated… Read more about this study
- Who is it for?
- Ages 20 to 22 yearsHealthy volunteers can take part
- Conditions the study is for
- Musculoskeletal Disorders, Among Egyptian Students in the Faculty of Applied Arts
- What is being tested?
- Arabic version of The Nordic Musculoskeletal Questionnaire (NMQ) is a standardized questionnaire used to assess musculoskeletal symptoms and disorders in the workplace
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 250 participants
- Where
- No sites listed yet
- Study dates
- 5 Jan 2025to 30 Jun 2025
- How long will I take part?
- 4 Weeks
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 22 years
- All sexes
- Healthy volunteers accepted
- Adult
Study population: students enrolled in the Faculty of Applied Art at a university in Egypt
Who may be able to join
- 250 Egyptian students from different Faculties of Applied Art.
- Age (20-22) years old
- both genders will be included.
Who cannot join
- Obesity.
- Pregnancy.
- Patients who had history of any other neuropathy.
- Unstable medical condition.
- Other neurological disorders causing pain as lumbar plexopathy, spinal stenosis, and spinal nerve root compression.
- History of central nervous system primary or metastatic malignancy
- student having any musculoskeletal problems due to other causes as accidents or a previous operation.
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Prevalence of Musculoskeletal Disorders Among Egyptian Students in the Faculty of Applied Arts
This observational cross-sectional study aims to determine the prevalence of musculoskeletal disorders (MSDs) among Egyptian students in the Faculty of Applied Arts. Using the Arabic version of the extended Nordic Musculoskeletal Questionnaire (NMQ-E), the study will assess the prevalence, distribution, and associated factors of musculoskeletal symptoms over the last 12 months and 7 days. A sample of 250 participants, aged 20-22 years and of both genders, will be recruited. Exclusion criteria include obesity, pregnancy, history of neuropathy, unstable medical conditions, or trauma-related musculoskeletal problems. The results will provide insights into MSD prevalence and help guide interventions for this population.
Read the detailed description
Study Title: Prevalence of Musculoskeletal Disorders Among Egyptian Students in the Faculty of Applied Arts
Study Design:
This is an observational, cross-sectional study aimed at investigating the prevalence of musculoskeletal disorders (MSDs) and associated risk factors among Egyptian students enrolled in the Faculty of Applied Arts during their last three academic years. The study will collect demographic data (age, gender) and assess musculoskeletal symptoms using the Nordic Musculoskeletal Questionnaire (NMQ-E).
Study Population:
The target population includes approximately 9,600 students from the Faculty of Applied Arts in Egypt. A sample of 250 participants will be recruited based on eligibility criteria.
Inclusion Criteria:
Egyptian students from the Faculty of Applied Arts. Age range: 20-22 years. Both genders included.
Exclusion Criteria:
Obesity. Pregnancy. History of neuropathy or other neurological disorders such as lumbar plexopathy, spinal stenosis, and nerve root compression.
Unstable medical conditions. History of central nervous system malignancy (primary or metastatic). Musculoskeletal problems due to trauma or previous surgery.
Sample Size Calculation:
The sample size was determined using a sample size calculator with a confidence interval of 95% and α level of 0.05. From a population of 9,600, a minimum of 250 participants was required to achieve statistical power.
Instrumentations:
The Arabic version of the extended Nordic Musculoskeletal Questionnaire (NMQ-E) will be utilized. The NMQ is a validated tool for assessing musculoskeletal symptoms, including pain prevalence and anatomical distribution.
Key Sections of NMQ-E:
Section 1: 40 forced-choice items identifying musculoskeletal problem areas, supported by a body map. Symptoms over the last 12 months and the past 7 days will be evaluated.
Section 2: Additional questions on neck, shoulders, and lower back, covering symptom duration, functional impact, professional assessments, and recent musculoskeletal problems.
Procedure:
Participants will be recruited from the Faculty of Applied Arts and asked to complete the NMQ-E online or in person. Data on musculoskeletal symptoms and ergonomic practices will be collected over a specific timeframe.
Validity and Reliability of NMQ-E:
Validity:
Content validity is supported by expert review and alignment with established measures of musculoskeletal health.
Criterion validity demonstrated strong correlations between NMQ responses and clinical assessments (sensitivity: 66-92%; specificity: 71-88%).
Reliability:
High test-retest reliability observed in various populations. Internal consistency confirmed via Cronbach's alpha.
Data Analysis and Statistical Design:
The collected data will be analyzed using statistical software, employing:
Descriptive statistics (mean, standard deviation, percentages). Statistical significance set at p < 0.05.
- Being tested
- Arabic version of The Nordic Musculoskeletal Questionnaire (NMQ) is a standardized questionnaire used to assess musculoskeletal symptoms and disorders in the workplace
- Keywords
- Prevalence, Musculoskeletal Disorders, Egyptian Students, Faculty of Applied Arts
- Medical subject headings
- Musculoskeletal Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Arabic version of The Nordic Musculoskeletal Questionnaire (NMQ) is a standardized questionnaire used to assess musculoskeletal symptoms and disorders in the workplaceBehavioural
The Nordic Musculoskeletal Questionnaire (NMQ) is a standardized questionnaire used to assess musculoskeletal symptoms and disorders in the workplace. It is commonly used in occupational health and ergonomic assessments to gather information about the prevalence and severity of musculoskeletal issues such as pain, discomfort, and limitations in movement. The NMQ typically includes questions about specific body regions (e.g. neck, shoulders, back, wrists) and asks individuals to report any symptoms they may be experiencing in those areas. This information can help identify potential risk factors for musculoskeletal disorders and guide interventions to prevent or manage these conditions in the workplace (Namnik et al., 2016).
- Section 1: a general questionnaire of 40 forced-choice items identifying areas of the body causing musculoskeletal problems. Completion is aided by a body map to indicate nine symptom sites being neck, shoulders, upper back, elbows, low back, wrist/hands, hips/thi
What is being measured
The primary outcome is the main question the study is designed to answer.
musculoskeletal symptoms
information on musculoskeletal symptoms experienced by participants,
Measured: one month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Nov 2024
- Study start5 Jan 2025 (estimated)
- Primary completionApr 2025 (estimated)
- Study completion30 Jun 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Musculoskeletal DisordersStudies of the same condition, open and under way.
- More trials run by Cairo UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 250 participants (estimated)
- Target duration
- 4 Weeks
Sponsor and investigators
- Lead sponsor
- Cairo University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Osama Abdelaziz, Cairo University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06709677
- Sponsor's protocol ID
- P.T.REC/012/005019
- Status last verified
- Nov 2024
- First submitted
- 26 Nov 2024
- Last updated
- 3 Dec 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 Dec 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prevalence of Musculoskeletal Disorders Among Egyptian Students in the Faculty of Applied Arts
- ClinicalTrials.gov ID
- NCT06709677
- Acronym / sponsor ID
- P.T.REC/012/005019
- Keywords
- Prevalence, Musculoskeletal Disorders, Egyptian Students, Faculty of Applied Arts
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 250 participants (estimated)
- Lead sponsor
- Cairo UniversityUniversity, hospital or other
- Study start
- 5 Jan 2025 (estimated)
- Primary completion
- Apr 2025 (estimated)
- Study completion
- 30 Jun 2025 (estimated)
- First posted
- 29 Nov 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This observational cross-sectional study aims to determine the prevalence of musculoskeletal disorders (MSDs) among Egyptian students in the Faculty of Applied Arts. Using the Arabic version of the extended Nordic Musculoskeletal Questionnaire (NMQ-E), the study will assess the prevalence, distribution, and associated factors of musculoskeletal symptoms over the last 12 months and 7 days. A sample of 250 participants, aged 20-22 years and of both genders, will be recruited. Exclusion criteria include obesity, pregnancy, history of neuropathy, unstable medical conditions, or trauma-related musculoskeletal problems. The results will provide insights into MSD prevalence and help guide interventions for this population.
Detailed description
Study Title: Prevalence of Musculoskeletal Disorders Among Egyptian Students in the Faculty of Applied Arts
Study Design:
This is an observational, cross-sectional study aimed at investigating the prevalence of musculoskeletal disorders (MSDs) and associated risk factors among Egyptian students enrolled in the Faculty of Applied Arts during their last three academic years. The study will collect demographic data (age, gender) and assess musculoskeletal symptoms using the Nordic Musculoskeletal Questionnaire (NMQ-E).
Study Population:
The target population includes approximately 9,600 students from the Faculty of Applied Arts in Egypt. A sample of 250 participants will be recruited based on eligibility criteria.
Inclusion Criteria:
Egyptian students from the Faculty of Applied Arts. Age range: 20-22 years. Both genders included.
Exclusion Criteria:
Obesity. Pregnancy. History of neuropathy or other neurological disorders such as lumbar plexopathy, spinal stenosis, and nerve root compression.
Unstable medical conditions. History of central nervous system malignancy (primary or metastatic). Musculoskeletal problems due to trauma or previous surgery.
Sample Size Calculation:
The sample size was determined using a sample size calculator with a confidence interval of 95% and α level of 0.05. From a population of 9,600, a minimum of 250 participants was required to achieve statistical power.
Instrumentations:
The Arabic version of the extended Nordic Musculoskeletal Questionnaire (NMQ-E) will be utilized. The NMQ is a validated tool for assessing musculoskeletal symptoms, including pain prevalence and anatomical distribution.
Key Sections of NMQ-E:
Section 1: 40 forced-choice items identifying musculoskeletal problem areas, supported by a body map. Symptoms over the last 12 months and the past 7 days will be evaluated.
Section 2: Additional questions on neck, shoulders, and lower back, covering symptom duration, functional impact, professional assessments, and recent musculoskeletal problems.
Procedure:
Participants will be recruited from the Faculty of Applied Arts and asked to complete the NMQ-E online or in person. Data on musculoskeletal symptoms and ergonomic practices will be collected over a specific timeframe.
Validity and Reliability of NMQ-E:
Validity:
Content validity is supported by expert review and alignment with established measures of musculoskeletal health.
Criterion validity demonstrated strong correlations between NMQ responses and clinical assessments (sensitivity: 66-92%; specificity: 71-88%).
Reliability:
High test-retest reliability observed in various populations. Internal consistency confirmed via Cronbach's alpha.
Data Analysis and Statistical Design:
The collected data will be analyzed using statistical software, employing:
Descriptive statistics (mean, standard deviation, percentages). Statistical significance set at p < 0.05.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Target follow-up
- 4 Weeks
Who may qualify
- Ages
- 20 to 22 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
- Study population
- students enrolled in the Faculty of Applied Art at a university in Egypt
Key inclusion criteria (3 listed)
- 250 Egyptian students from different Faculties of Applied Art.
- Age (20-22) years old
- both genders will be included.
Key exclusion criteria (7 listed)
- Obesity.
- Pregnancy.
- Patients who had history of any other neuropathy.
- Unstable medical condition.
- Other neurological disorders causing pain as lumbar plexopathy, spinal stenosis, and spinal nerve root compression.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Arabic version of The Nordic Musculoskeletal Questionnaire (NMQ) is a standardized questionnaire used to assess musculoskeletal symptoms and disorders in the workplaceThe Nordic Musculoskeletal Questionnaire (NMQ) is a standardized questionnaire used to assess musculoskeletal symptoms and disorders in the workplace. It is commonly used in occupational health and ergonomic assessments to gather information about the prevalence and severity of musculoskeletal issues such as pain, discomfort, and limitations in movement. The NMQ typically includes questions about specific body regions (e.g. neck, shoulders, back, wrists) and asks individuals to report any symptoms they may be experiencing in those areas. This information can help identify potential risk factors for musculoskeletal disorders and guide interventions to prevent or manage these conditions in the workplace (Namnik et al., 2016). • Section 1: a general questionnaire of 40 forced-choice items identifying areas of the body causing musculoskeletal problems. Completion is aided by a body map to indicate nine symptom sites being neck, shoulders, upper back, elbows, low back, wrist/hands, hips/thi | Behavioural | – |
Primary outcome
musculoskeletal symptoms
Time frame: one month
information on musculoskeletal symptoms experienced by participants,
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Dec 2024.
Related trials for Musculoskeletal Disorders
Not yet recruitingPhase 2
Extension Study of Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis (CDDY391A12201-extension)
Moderate to Severe Psoriatic Arthritis
RecruitingPhase 2
Study of PTC844 in Participants With Active Rheumatoid Arthritis
Rheumatoid Arthritis
RecruitingPhase 1/2
A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia
X-linked Hypophosphatemia
Recruiting
Effects of Cervicothoracic Mobilization in Patients With Supraspinatus Tendinitis
Rotator Cuff Tendonitis
Not yet recruitingPhase 1
An Ascending Dose Study of DKB903 in Participants With Rheumatoid Arthritis (RA) and Participants With Systemic Lupus Erythematosus (SLE)
Rheumatoid Arthritis and Systemic Lupus Erythematosus
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Questions about this trial
What is this clinical trial studying?
An observational study of Musculoskeletal Disorders and Among Egyptian Students in the Faculty of Applied Arts, run by Cairo University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 3 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Osama Abdelaziz physiotherapist, Master Degree (+20 102 530 6119, Osamasalih143@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
musculoskeletal symptoms (time frame: one month). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Dec 2024.